Association between use of acid-suppressive medications and antibiotics during infancy and allergic diseases in early childhood

JAMA Pediatrics

Volumn 172, Issue 6, 2018, Pages

  Mitre, Edward ^a   Susi, Apryl ^a   Kropp, Laura E ^a   Schwartz, David J ^b   Gorman, Gregory H ^a   Nylund, Cade M ^a  

^a Uniformed Services University of the Health Sciences   (United States)

^b EISENHOWER ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; MACROLIDE; PENICILLIN DERIVATIVE; PRESCRIPTION DRUG; PROTON PUMP INHIBITOR; ANTIINFECTIVE AGENT;

ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ALLERGIC DISEASE; ALLERGIC RHINITIS; ALLERGY; ANAPHYLAXIS; ARTICLE; ATOPIC DERMATITIS; CASE CONTROL STUDY; CESAREAN SECTION; CHILD; CHILDHOOD; CHILDHOOD DISEASE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTACT DERMATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; DRUG USE; EARLY LIFE STRESS; EGG ALLERGY; FEMALE; FOOD ALLERGY; HIGH RISK PATIENT; HUMAN; HYPOTHESIS; INCIDENCE; INFANCY; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MILK ALLERGY; OUTCOME ASSESSMENT; PEANUT ALLERGY; PREMATURITY; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; URTICARIA; DRUG EFFECT; HYPERSENSITIVITY; INTESTINE FLORA; NEWBORN; PRESCHOOL CHILD;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; GASTROINTESTINAL MICROBIOME; HISTAMINE H2 ANTAGONISTS; HUMANS; HYPERSENSITIVITY; INFANT; INFANT, NEWBORN; MALE; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 85048659866     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2018.0315     Document Type: Article

References (41)

1. Branum AM, Lukacs SL. Food allergy among children in the United States. Pediatrics. 2009;124 (6):1549-1555.
2. Koplin JJ, Mills EN, Allen KJ. Epidemiology of food allergy and food-induced anaphylaxis: is there really aWestern world epidemic? Curr Opin Allergy Clin Immunol. 2015;15(5):409-416.
3. Platts-Mills TA. The allergy epidemics: 1870-2010. J Allergy Clin Immunol. 2015;136(1):3-13.
4. Sicherer SH, Muñoz-Furlong A, Godbold JH, Sampson HA. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol. 2010;125(6): 1322-1326.
5. Asher MI, Montefort S, Björkstén B, et al; ISAAC Phase Three Study Group.Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537): 733-743.
6. EderW, EgeMJ, von Mutius E. The asthma epidemic. N Engl J Med. 2006;355(21):2226-2235.
7. Rönmark E, Bjerg A, Perzanowski M, Platts-Mills T, Lundbäck B. Major increase in allergic sensitization in schoolchildren from 1996 to 2006 in northern Sweden. J Allergy Clin Immunol. 2009;124(2):357-363, 63.e1-63.e15.
8. Mulla ZD, Lin RY, Simon MR. Perspectives on anaphylaxis epidemiology in the United States with new data and analyses. Curr Allergy Asthma Rep. 2011;11(1):37-44.
9. Poulos LM,Waters AM, Correll PK, Loblay RH, Marks GB. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. J Allergy Clin Immunol. 2007;120(4):878-884.
10. Pali-Schöll I, Jensen-Jarolim E. Anti-acid medication as a risk factor for food allergy. Allergy. 2011;66(4):469-477.
11. Prince BT, Mandel MJ, Nadeau K, Singh AM. Gut microbiome and the development of food allergy and allergic disease. Pediatr Clin North Am. 2015;62 (6):1479-1492.
12. Reynolds LA, Finlay BB. A case for antibiotic perturbation of the microbiota leading to allergy development. Expert Rev Clin Immunol. 2013;9(11): 1019-1030.
13. Untersmayr E, Jensen-Jarolim E. The role of protein digestibility and antacids on food allergy outcomes. J Allergy Clin Immunol. 2008;121(6): 1301-1308.
14. Marsland BJ, Salami O. Microbiome influences on allergy in mice and humans. Curr Opin Immunol. 2015;36:94-100.
15. Arrieta MC, Stiemsma LT, Dimitriu PA, et al; CHILD Study Investigators. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med. 2015;7(307):307ra152.
16. Untersmayr E, Schöll I, Swoboda I, et al. Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in BALB/c mice. J Allergy Clin Immunol. 2003;112(3): 616-623.
17. Riemer AB, Gruber S, Pali-Schöll I, Kinaciyan T, Untersmayr E, Jensen-Jarolim E. Suppression of gastric acid increases the risk of developing immunoglobulin E-mediated drug hypersensitivity: human diclofenac sensitization and a murine sensitization model. Clin Exp Allergy. 2010;40(3): 486-493.
18. Untersmayr E, Bakos N, Schöll I, et al. Anti-ulcer drugs promote IgE formation toward dietary antigens in adult patients. FASEB J. 2005;19(6): 656-658.
19. Ramírez E, Cabañas R, Laserna LS, et al. Proton pump inhibitors are associated with hypersensitivity reactions to drugs in hospitalized patients: a nested case-control in a retrospective cohort study. Clin Exp Allergy. 2013;43(3):344-352.
20. Trikha A, Baillargeon JG, Kuo YF, et al. Development of food allergies in patients with gastroesophageal reflux disease treated with gastric acid suppressive medications. Pediatr Allergy Immunol. 2013;24(6):582-588.
21. American Society of Health-System Pharmacists. AHFS pharmacologic-therapeutic classification. In: McEvoy GK, ed. AHFS Drug Information 2018. Bethesda, MD: American Society of Health-System Pharmacists; 2018:viii-x.
22. Guthrie D. Analysis of dichotomous variables in repeated measures experiments. Psychol Bull. 1981; 90(1):189-195.
23. Allison PD. In: SAS Institute, ed. Interactions With Time as Time-Dependent Covariates-Survival Analysis Using the SAS System: A Practical Guide. 2nd ed. Cary, North Carolina: SAS Institute; 2010:177-178.
24. Cantor AB. SAS Survival Analysis Techniques for Medical Research. 2nd ed. Cary, North Carolina: SAS Institute; 2003.
25. Arae K, Oboki K, Ohno T, et al. Cimetidine enhances antigen-specific IgE and Th2 cytokine production. Allergol Int. 2011;60(3):339-344.
26. MurkW, Risnes KR, Bracken MB. Prenatal or early-life exposure to antibiotics and risk of childhood asthma: a systematic review. Pediatrics. 2011;127(6):1125-1138.
27. Hirsch AG, Pollak J, Glass TA, et al. Early-life antibiotic use and subsequent diagnosis of food allergy and allergic diseases. Clin Exp Allergy. 2017; 47(2):236-244.
28. Rachid R, Chatila TA. The role of the gut microbiota in food allergy. Curr Opin Pediatr. 2016; 28(6):748-753.
29. Lynch SV, Boushey HA. The microbiome and development of allergic disease. Curr Opin Allergy Clin Immunol. 2016;16(2):165-171.
30. Stefka AT, Feehley T, Tripathi P, et al. Commensal bacteria protect against food allergen sensitization. Proc Natl Acad Sci U S A. 2014;111(36): 13145-13150.
31. Russell SL, Gold MJ, Hartmann M, et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 2012;13 (5):440-447.
32. O'Mahony L, Akdis M, Akdis CA. Regulation of the immune response and inflammation by histamine and histamine receptors. J Allergy Clin Immunol. 2011;128(6):1153-1162.
33. Nelson SP, Kothari S,Wu EQ, Beaulieu N, McHale JM, Dabbous OH. Pediatric gastroesophageal reflux disease and acid-related conditions: trends in incidence of diagnosis and acid suppression therapy. J Med Econ. 2009;12(4): 348-355.
34. Barron JJ, Tan H, Spalding J, Bakst AW, Singer J. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr. 2007;45(4): 421-427.
35. Hudson B, Alderton A, Doocey C, Nicholson D, Toop L, Day AS. Crying and spilling-time to stop the overmedicalisation of normal infant behaviour.N Z Med J. 2012;125(1367):119-126.
36. van der Pol R, Langendam M, Benninga M, van Wijk M, Tabbers M. Efficacy and safety of histamine-2 receptor antagonists. JAMA Pediatr. 2014;168(10):947-954.
37. Orenstein SR, Hassall E, Furmaga-JablonskaW, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr. 2009; 154(4):514-520.e4.
38. Moore DJ, Tao BS, Lines DR, Hirte C, Heddle ML, Davidson GP. Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux. J Pediatr. 2003;143(2): 219-223.
39. Hassall E. Over-prescription of acid-suppressing medications in infants: how it came about, why it's wrong, and what to do about it. J Pediatr. 2012;160(2):193-198.
40. Farahmand F, NajafiM, Ataee P, Modarresi V, Shahraki T, Rezaei N. Cow's milk allergy among children with gastroesophageal reflux disease. Gut Liver. 2011;5(3):298-301.
41. Schoemaker AA, Sprikkelman AB, Grimshaw KE, et al. Incidence and natural history of challenge-proven cow's milk allergy in European children-EuroPrevall birth cohort. Allergy. 2015;70 (8):963-972.